| 产品详情 |
| Edit |   |
| Product Name | Recombinant Human Prostaglandin-H2 D-isomerase |
| Description | 23-190aa; Full Length. MW: 34.69kD. Purity >90% as determined by SDS-PAGE. Catalyzes the conversion of PGH2 to PGD2, a prostaglandin involved in smooth muscle contraction/relaxation and a potent inhibitor of platelet aggregation. Involved in a variety of CNS functions, such as sedation, NR sleep and PGE2-induced allodynia, and may have an anti-apoptotic role in oligodendrocytes. Binds small non-substrate lipophilic molecules, including biliverdin, bilirubin, retinal, retinoic acid and thyroid ho |
| Size | 0.05 mg (E-Coli), 0.05 mg (Yeast), 0.2 mg (E-Coli), 0.5 mg (E-Coli), 0.05 mg (Baculovirus) |
| Concentration | n/a |
| Applications | n/a |
| Other Names | [Beta-trace protein; Cerebrin-28; Glutathione-independent PGD synthase; Lipocalin-type prostaglandin-D synthase; Prostaglandin-D2 synthase; PGD2 synthase; PGDS; PGDS2] |
| Gene, Accession, CAS # | PTGDS, Gene ID: 5730, Accession: NP_000945.3 |
| Catalog # | MBS717549 |
| Price | |
| Order / More Info | Recombinant Human Prostaglandin-H2 D-isomerase from MYBIOSOURCE INC. |
| Product Specific References | Human brain prostaglandin D synthase has been evolutionarily differentiated from lipophilic-ligand carrier proteins.Nagata A., Suzuki Y., Igarashi M., Eguchi N., Toh H., Urade Y., Hayaishi O.Proc. Natl. Acad. Sci. U.S.A. 88:4020-4024(1991) |
| 产品资料 |
|
|